InsiderTrades

Form 4 for ORCL Oracle Corporation

Accepted 2025-09-16 00:00:00 ET · period of report 2025-09-12 · accession 0001341439-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-09-16 2025-09-15 ORCL Magouyrk Clayton M. Pres, OCI M - OptEx — +61.5K 139.5K +79% —
D 2025-09-16 2025-09-15 ORCL Magouyrk Clayton M. Pres, OCI F - Tax $292.18 -24.2K 115.3K -17% -$7.07M
D 2025-09-16 2025-09-12 ORCL Magouyrk Clayton M. Pres, OCI S - Sale+OE $297.11 -21.2K 78.0K -21% -$6.31M
D 2025-09-16 2025-09-15 ORCL Magouyrk Clayton M. Pres, OCI M - OptEx — -61.5K 122.9K -33% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-09-15 M A 61,452 — 139,452 D — — (F1) The restricted stock units vest in four equal annual installments, beginning on the first anniversary of the date of grant.
2 Common Common Stock 2025-09-15 F D 24,182 $292.18 115,270 D — —
3 Common Common Stock 2025-09-12 S D 21,241 $297.11 78,000 D — —
4 Derivative Restricted Stock Unit 2025-09-15 M D 61,452 — 122,905 D — · — to — 61,452 Common Stock (F1) The restricted stock units vest in four equal annual installments, beginning on the first anniversary of the date of grant. (F2) Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock. (F3) The RSUs vest in four equal annual installments, beginning on the first anniversary of the date of the grant.